| |
The Brenda E. & Roger S. Luca Family Endowment Challenges Triple Negative Breast Cancer
  About Triple Negative Breast Cancer
- Triple negative breast cancer is an important, under- researched subtype of breast cancer. Most breast cancers are characterized by the presence of three receptors: estrogen, progesterone and HER2. None of these three receptors is found in women with this subtype breast cancer; thus, the designation — triple negative breast cancer.
- Most of the breast cancer treatments available today target these three receptors. Unfortunately, triple negative tumors do not respond. Triple negative breast cancer is more prevalent among young women and African American women. The more we know about this subtype of breast cancer, the more likely we are to find targeted treatment for this disease.
- The research agenda for triple negative breast cancer is growing. The field is wide open to bring clinical researchers and basic scientists together to discover and deliver new treatments for patients as quickly as possible.
- The Luca Family Endowment’s express intent is to fund research initiatives related to triple negative breast cancer and to fund cancer treatment and other cancer patient care needs for those in the greater Tallahassee area who, while gainfully employed, are either under-insured or uninsured.
"You don’t always get to choose the path you walk in life, but you do get to choose how you walk it."
Brenda Luca {1957-2007} |
 |
|
|
 |
|
|
|
